SETD3 and hepatocellular carcinoma: To further consolidate this result, commercial purchased liver tumor tissue microarrays containing 24 pairs of human hepatocellular carcinoma and adjacent pairs of tissues were immunostained with α-SETD3 or α-PLK1 antibodies, respectively (Figure 4E).